search
Back to results

Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial

Primary Purpose

Esophageal Neoplasm

Status
Completed
Phase
Not Applicable
Locations
Croatia
Study Type
Interventional
Intervention
Restrictive group
Liberal group
Sponsored by
Klinički Bolnički Centar Zagreb
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Esophageal Neoplasm focused on measuring intraoperative, fluid management, esophageal carcinoma, surgery, gas exchange, tissue perfusion

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • esophageal carcinoma
  • Lewis Tanner procedure (median laparotomy and right thoracotomy)

Exclusion Criteria:

  • younger than 18 years
  • severe lung disease
  • chronic renal insufficiency
  • a physical status classification > III on the American Society of Anesthesiologists (ASA) scale
  • impossible to perform epidural catheter placement
  • thoraco-phreno-laparotomy

Sites / Locations

  • Department of Thoracic surgery "Jordanovac" University Hospital Centre Zagreb

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Restrictive group

Liberal group

Arm Description

Patients who received ≤ 8ml/kg/h of intraoperative fluid. A fluid administered during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.

Patients who received > 8 ml/kg/h of fluid. A fluid used during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.

Outcomes

Primary Outcome Measures

Pulmonary Gas Exchange During and After Esophageal Carcinoma Surgery (PaO2/FiO2 Ratio)
At the given time point, 10 minutes after beginning of the Lewis Tanner procedure and 6 hours after, arterial oxygen partial pressure (PaO2), inspired oxygen fraction (FiO2), and the PaO2/FiO2 ratio will be measured. The results of Pa02/FiO2 ratio will be compared between two groups for each time point separately.
Creatinine Values During and After Esophageal Carcinoma Surgery
At the given time points, 10 minutes after beginning of the Lewis Tanner procedure and 6 hours after, creatinine blood levels will be measured. The results will be compared between two groups for each time point separately.
Lactate Values During and After Esophageal Carcinoma Surgery
At the given time points, ten minutes after beginning of the Lewis Tanner procedure and six hours after procedure, blood levels of the lactate will be measured and compared between two groups for each time point separately.
Changes in Lactate Levels During Esophageal Carcinoma Surgery Using Restrictive or Liberal Fluid Management.
At the given time points, ten minutes after beginning of the Lewis Tanner procedure and six hours after procedure, blood levels of the lactate will be measured and compared inside the same group (liberal or restrictive).

Secondary Outcome Measures

Duration of Surgery
Total time of Lewis-Tanner procedure will be measured and compared between two groups.
Total Volume of Administered Intraoperative Fluid
Total volume of intraoperatively given fluid according to the protocol will be measured and compared between two groups.

Full Information

First Posted
January 7, 2014
Last Updated
April 23, 2014
Sponsor
Klinički Bolnički Centar Zagreb
search

1. Study Identification

Unique Protocol Identification Number
NCT02033213
Brief Title
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
Official Title
Intraoperative Volume Restriction in Esophageal Carcinoma Surgery: an Exploratory Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
June 2011 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
August 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Klinički Bolnički Centar Zagreb

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
An exploratory single-centre randomized clinical trial was performed in order to investigate whether the fluid volume administered during esophageal carcinoma surgery affects pulmonary gas exchange and tissue perfusion.
Detailed Description
A convenience sample of 16 patients admitted to the Department of Thoracic surgery University Hospital Centre Zagreb and scheduled for esophageal carcinoma surgery were enrolled prospectively in the study between June 2011 and August 2012. Patients were randomly allocated into two groups, one of which received ≤ 8ml/kg/h of intraoperative fluid ("restrictive group") and another that received > 8 ml/kg/h of fluid ("liberal group"). Patients were excluded if they were younger than 18 years; if they had severe lung disease, chronic renal insufficiency, or a physical status classification > III on the American Society of Anesthesiologists (ASA) scale; or if it was impossible to perform epidural catheter placement or thoraco-phreno-laparotomy. All patients underwent esophagectomy carried out according to the Lewis-Tanner approach. Data on arterial oxygen partial pressure (PaO2), inspired oxygen fraction (FiO2), and the ratio PaO2/FiO2 were collected 10 min after anesthesia was induced and again 6 h after surgery. Data on the metabolic markers creatinine and lactate were collected 10 min after anesthesia induction and 6 h after surgery. ANOVA tests were performed to determine significant differences in mean values between study groups. Independent-sample t-tests were used to test differences in mean values between the restrictive and liberal groups for each of the two sets of measurements separately (10 minutes after anesthesia induction and 6 hr after surgery). P < 0.05 was considered significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Neoplasm
Keywords
intraoperative, fluid management, esophageal carcinoma, surgery, gas exchange, tissue perfusion

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Restrictive group
Arm Type
Active Comparator
Arm Description
Patients who received ≤ 8ml/kg/h of intraoperative fluid. A fluid administered during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.
Arm Title
Liberal group
Arm Type
Active Comparator
Arm Description
Patients who received > 8 ml/kg/h of fluid. A fluid used during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.
Intervention Type
Other
Intervention Name(s)
Restrictive group
Other Intervention Name(s)
Intraoperative restrictive fluid management
Intervention Description
A group of patients who received ≤ 8ml/kg/h of intraoperative fluid during esophageal carcinoma surgery. The fluid administered: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.
Intervention Type
Other
Intervention Name(s)
Liberal group
Other Intervention Name(s)
Intraoperative liberal fluid management
Intervention Description
A group of patients who received > 8 ml/kg/h of intraoperative fluid during esophageal carcinoma surgery. The fluid admnistered: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.
Primary Outcome Measure Information:
Title
Pulmonary Gas Exchange During and After Esophageal Carcinoma Surgery (PaO2/FiO2 Ratio)
Description
At the given time point, 10 minutes after beginning of the Lewis Tanner procedure and 6 hours after, arterial oxygen partial pressure (PaO2), inspired oxygen fraction (FiO2), and the PaO2/FiO2 ratio will be measured. The results of Pa02/FiO2 ratio will be compared between two groups for each time point separately.
Time Frame
10 minutes, 6 hours
Title
Creatinine Values During and After Esophageal Carcinoma Surgery
Description
At the given time points, 10 minutes after beginning of the Lewis Tanner procedure and 6 hours after, creatinine blood levels will be measured. The results will be compared between two groups for each time point separately.
Time Frame
10 minutes, 6 hours
Title
Lactate Values During and After Esophageal Carcinoma Surgery
Description
At the given time points, ten minutes after beginning of the Lewis Tanner procedure and six hours after procedure, blood levels of the lactate will be measured and compared between two groups for each time point separately.
Time Frame
10 minutes, 6 hours
Title
Changes in Lactate Levels During Esophageal Carcinoma Surgery Using Restrictive or Liberal Fluid Management.
Description
At the given time points, ten minutes after beginning of the Lewis Tanner procedure and six hours after procedure, blood levels of the lactate will be measured and compared inside the same group (liberal or restrictive).
Time Frame
10 minutes, 6 hours
Secondary Outcome Measure Information:
Title
Duration of Surgery
Description
Total time of Lewis-Tanner procedure will be measured and compared between two groups.
Time Frame
End of surgery.
Title
Total Volume of Administered Intraoperative Fluid
Description
Total volume of intraoperatively given fluid according to the protocol will be measured and compared between two groups.
Time Frame
End of surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: esophageal carcinoma Lewis Tanner procedure (median laparotomy and right thoracotomy) Exclusion Criteria: younger than 18 years severe lung disease chronic renal insufficiency a physical status classification > III on the American Society of Anesthesiologists (ASA) scale impossible to perform epidural catheter placement thoraco-phreno-laparotomy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maja Karaman Ilić, MD PhD
Organizational Affiliation
Clinical Hospital Centre Zagreb
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Thoracic surgery "Jordanovac" University Hospital Centre Zagreb
City
Zagreb
State/Province
City of Zagreb
ZIP/Postal Code
10 000
Country
Croatia

12. IPD Sharing Statement

Citations:
PubMed Identifier
26088854
Citation
Karaman Ilic M, Madzarac G, Kogler J, Stancic-Rokotov D, Hodoba N. Intraoperative volume restriction in esophageal cancer surgery: an exploratory randomized clinical trial. Croat Med J. 2015 Jun;56(3):290-6. doi: 10.3325/cmj.2015.56.290.
Results Reference
derived

Learn more about this trial

Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial

We'll reach out to this number within 24 hrs